NCT06881277 Effectiveness of a Smartphone App (PRIMI) to Promote Healthy Diet and Physical Activity After Pregnancy in Migrant Women
| NCT ID | NCT06881277 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Linkoeping University |
| Condition | Postpartum |
| Study Type | INTERVENTIONAL |
| Enrollment | 200 participants |
| Start Date | 2025-10-13 |
| Primary Completion | 2027-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 200 participants in total. It began in 2025-10-13 with a primary completion date of 2027-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The PRIMI trial (Promoting Reproductive health In MIgrant women) is a randomized controlled trial evaluating the effectiveness of a smartphone app designed to promote a healthy diet, physical activity, and health literacy among first-generation migrant women after pregnancy. The study will recruit 200 women within six months after pregnancy and randomize them into an intervention group, receiving access to the PRIMI app for six months, or a wait-list control group. The primary outcomes are diet quality and moderate-to-vigorous physical activity, while secondary outcomes include health literacy, body mass index, self-efficacy, and self-rated health. The intervention is expected to provide accessible and culturally tailored support to improve postpartum health behaviors.
Eligibility Criteria
Inclusion Criteria: * First-generation migrant women * Given birth ≤ 6 months ago * Age ≥ 18 years * Able to receive health-related information in Arabic, Somali, English, or Swedish Exclusion Criteria: * Swedish-born women * Age \< 18 years * Given birth \> 6 months ago
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06881277 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Postpartum. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06881277 currently recruiting?
Yes, NCT06881277 is actively recruiting participants. Contact the research team at pontus.henriksson@liu.se for enrollment information.
Where is the NCT06881277 trial being conducted?
This trial is being conducted at Linköping, Sweden.
Who is sponsoring the NCT06881277 clinical trial?
NCT06881277 is sponsored by Linkoeping University. The trial plans to enroll 200 participants.